Kaiser Permanente Northern California Gynecologic Cancer Program, and the Department of Obstetrics, Gynecology, and Reproductive Sciences, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, Salud Para La Gente, Watsonville, Kaiser Permanente Northern California, Division of Research, Oakland, and Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Corresponding author: Alexandra (Jana) H. Freeman, MD, Helen Diller Family Comprehensive Cancer Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, 550 16th Street, 7th Floor, San Francisco, CA 94143; email: [email protected].
Financial support of this article was provided by Kaiser Permanente Northern California Graduate Medical Education Program, Kaiser Foundation Hospitals.
Financial Disclosure The authors did not report any potential conflicts of interest.
Presented at the Western Association of Gynecologic Oncologists’ annual meeting, June 14–17, 2017, Rancho Mirage, California.
Each author has indicated that he or she has met the journal's requirements for authorship.
